Waki Tylosin

• PRESENTATION

Tylosin is a macrolide antibiotic produced by a strain of Streptomycse fradiae. fradiae. It exerts its antimicrobial effect by inhibiting protein synthesis of susceptible micro-organisms. The Tylosin spectrum of activity includes amongst others Gram- positive bacteria, some Gram – negative strains such as Pasteurella, and Mycoplasma spp. In most species peak plasma concentrations have been attained 1to 2 hours after administration of tylosin. Compared to plasma levels clearly higher tissue concentration have been observed. Tylosin was extensively metabolished.

• INDICATIONS

 Broiler Chicken: Treatment of chronic respiratory diseases (CDR) caused by Mycoplasma gallisepticum and My coplasma synoviae . Turkeys: Treatment of infectious sinusities caused by Mycoplasma gallisepticum 

• COMPOSITION

Each 1.10 gm contains 1.10gm Tylosin tartrate. Eqivalent to 1 gm Taylosin base

• DOSAGE & ROUTE OF ADMINISTRATION

Route of administration: orally via drinking water
For whole product
Turkeys: 0.55-0.825 gm waki-tylosin/litre per drinking water for 3-5 days. Broiler Chickens; For the treatment of chronic respiratory disease:0.55-0.825 gm waki-tylosin/litre per drinking water for 3-5 days. For the treatment of necrotic enterities:0.44 gm Taylor/litre per day for 3 days

•  CONTRA –INDICATION

Do not use in cases of known resistance to Tylosin or cross-resistance to other marcrolide (MLS-resistance). DO not use in animals vaccinated with Tylosin-sensitive vaccines either at the same time or within 1 week previously

• WITHDRAWAL PERIOD

Turkeys (meat and offal): 2 days Broiler Chickens ( meat and offal): 1day

• TARGET SPECIES

Broiler Chickens and Turkeys

• STORAGE

Stored at temperature not exceed 30 C˚.

• side effect

 there is no evidence of tylosin toxicity in chickens, turkeys, or claves when administered orally at up to three times the recommended dose

•WARNING & PRECAUTION

Do not use in houres . Do not use in animals with hepatic disorders